SCHEMBL6095205

SCHEMBL6095205

O=C1C=C(Cl)C(=O)C(c2c[nH]c3c2ccc2ccccc23)=C1Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK2A2 P19784 1/20 0.41
CSNK2B P67870 1/20 0.41
CSNK2A1 P68400 1/20 0.41
AR P10275 9/20 0.39
CDC25A P30304 1/20 0.34
CDC25C P30307 1/20 0.34
ALDH1A1 P00352 2/20 0.34
HPGD P15428 2/20 0.34
KDM4E B2RXH2 1/20 0.34
HTT P42858 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
PRKD3 O94806 1/20 0.33
CCNB2 O95067 1/20 0.33
CCNE2 O96020 1/20 0.33
ABL1 P00519 1/20 0.33
PRKCG P05129 1/20 0.33
PRKCB P05771 1/20 0.33
CDK1 P06493 1/20 0.33
PIM1 P11309 1/20 0.33
CDK4 P11802 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6097786 0.84 DYRK1A (0.43) ARPRKCBPRKCAPRKCHPRKCE
SCHEMBL6094634 0.82 PARP1 (0.40) ARALDH1A1KDM4EPRKD3CCNB2
SCHEMBL6096554 0.82 DYRK1A (0.41) ARPIM1CAMK2D
SCHEMBL6096052 0.82 GPR84 (0.40) ARCCNE1CDK2
SCHEMBL6097207 0.82 AR (0.44) ARALDH1A1HPGDKDM4EHTT
SCHEMBL6097734 0.81 PRKCB (0.54) HTTPRKD3CCNB2CCNE2ABL1
SCHEMBL6099160 0.79 CSNK2A2 (0.34) CSNK2A2CSNK2BCSNK2A1
SCHEMBL6095726 0.79 ALDH1A1 (0.44) ARALDH1A1HPGDKDM4EHTT
SCHEMBL6096077 0.79 AR (0.35) ARKDM4ESMN1; SMN2PRKCBPRKCA
SCHEMBL6097186 0.77 MEN1 (0.37) ARALDH1A1HTTMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7057052-B2 Heterocyclic quinones as pharmaceutical agents DUKE UNIVERSITY (US) 2006-06-06 US disclosed
US-20040063774-A1 Heterocyclic quinones as pharmaceutical agents DUKE UNIVERSITY 2004-04-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040063774-A1 Heterocyclic quinones as pharmaceutical agents NQO1, RECQL, SDHA CSNK2A2 3333/4885CSNK2B 3574/4885CSNK2A1 3299/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.